MAPT and Alzheimer disease: In Alzheimer's disease (AD), EVs have been shown to influence pathological events, carrying neurotoxins, such as neuroinflammatory factors, pathogenic forms of amyloid‐β, and phosphorylated tau into recipient neurons.